“IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?” (2021) Mediterranean Journal of Hematology and Infectious Diseases, 13(1), p. e2021062. doi:10.4084/MJHID.2021.062.